Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Kailera Therapeutics, Inc. (KLRA) had Return on Equity of 41.79% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-148.96M |
|
-- |
|
-- |
|
158.34M |
|
-158.34M |
|
9.38M |
|
-148.96M |
|
-148.96M |
|
-148.96M |
|
-148.96M |
|
-148.96M |
|
-148.96M |
|
-158.34M |
|
-158.03M |
|
0.00M |
|
0.00M |
|
-949.00 |
|
-949.00 |
|
| Balance Sheet Financials | |
557.54M |
|
1.96M |
|
134.76M |
|
692.29M |
|
46.41M |
|
-- |
|
9.98M |
|
56.39M |
|
-356.46M |
|
635.91M |
|
635.91M |
|
0.02M |
|
| Cash Flow Statement Financials | |
-120.21M |
|
-492.60M |
|
598.66M |
|
175.18M |
|
161.03M |
|
-14.15M |
|
10.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-122.30M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
41.79% |
-23.42% |
|
-21.52% |
|
-23.42% |
|
0.03M |
|
-- |
|
-- |
|